2-n-propyl-4-pentynoic acid has been researched along with Abnormalities, Drug-Induced in 1 studies
*Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, JE; Bojic, U; Ebron-McCoy, MT; Kavlock, RJ; Nau, H | 1 |
1 other study(ies) available for 2-n-propyl-4-pentynoic acid and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Stereoselective dysmorphogenicity of the enantiomers of the valproic acid analogue 2-N-propyl-4-pentynoic acid (4-yn-VPA): cross-species evaluation in whole embryo culture.
Topics: Abnormalities, Drug-Induced; Animals; Embryonic and Fetal Development; Fatty Acids, Unsaturated; Female; Male; Mice; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Species Specificity; Stereoisomerism; Teratogens; Valproic Acid | 1997 |